Bausch Health Companies (BHC) Total Debt Growth (3y) (2012 - 2026)
Powered by 
Analysis
Bausch Health Companies (BHC) Total Debt Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.81 Bn | 39.16 Bn | 2.15 Bn | -7.08% |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn | -10.47% |
| 3 | Dr Reddys Laboratories | 9.90 Bn | 9.73 Bn | 396.53 Mn | 74.38% |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn | -0.36% |
| 5 | Bausch Health Companies | 2.32 Bn | 479.50 Mn | 2.10 Bn | 0.96% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.12 Bn | 165.89 Mn | -0.95% |
| 8 | Amphastar Pharmaceuticals | 997.70 Mn | 707.58 Mn | 93.47 Mn | 6.89% |
| 9 | Fennec Pharmaceuticals | 395.89 Mn | 354.64 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 179.21 Mn | 179.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.96% |
| Mar 31, 2026 | 0.87% |
| Dec 31, 2025 | -0.25% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | 0.98% |
| Mar 31, 2025 | -2.02% |
| Dec 31, 2024 | 2.35% |
| Sep 30, 2024 | -0.60% |
| Jun 30, 2024 | -1.92% |
| Mar 31, 2024 | -1.61% |
| Dec 31, 2023 | -1.54% |
| Sep 30, 2023 | -1.92% |
| Jun 30, 2023 | -4.83% |
| Mar 31, 2023 | -4.77% |
| Dec 31, 2022 | -7.89% |
| Sep 30, 2022 | -2.96% |
| Jun 30, 2022 | -3.09% |
| Mar 31, 2022 | -1.76% |
| Dec 31, 2021 | -2.62% |
| Sep 30, 2021 | -3.69% |